When Transfer Of Drug Patent Rights Is Reportable To FTC
On Nov. 6, the Federal Trade Commission released finalized amendments to the premerger notification rules (the rule), which clarify when the transfer of pharmaceutical (including biological) patent rights is reportable to...To view the full article, register now.
Already a subscriber? Click here to view full article